Your browser does not support JavaScript!

Preferential hyperacuity perimetry: home monitoring to decrease vision loss due to age-related macular degeneration

Preferential hyperacuity perimetry: home monitoring to decrease vision loss due to age-related macular degeneration

For access to this article, please select a purchase option:

Buy chapter PDF
(plus tax if applicable)
Buy Knowledge Pack
10 chapters for $120.00
(plus taxes if applicable)

IET members benefit from discounts to all IET publications and free access to E&T Magazine. If you are an IET member, log in to your account and the discounts will automatically be applied.

Learn more about IET membership 

Recommend Title Publication to library

You must fill out fields marked with: *

Librarian details
Your details
Why are you recommending this title?
Select reason:
Patient-Centered Digital Healthcare Technology: Novel applications for next generation healthcare systems — Recommend this title to your library

Thank you

Your recommendation has been sent to your librarian.

Vision is one of the most valued of human sensory perceptions, and vision loss is associated with a significant decrease in quality of life as well as serious medical, psychological, social and financial consequences. Due to the high value people place on vision, ophthalmologists often find that patients are motivated to take an active role in reducing their risk for vision loss. Age-related macular degeneration (AMID) is the leading cause of irreversible vision loss in the western world. Despite major advances in treating this condition over the past two decades, additional efforts are needed to significantly alter current rates of visual decline due to AMID. This unmet need provides an opportunity to utilise home monitoring technology to enable self-aware AMID patients to preserve their vision. Remote patient monitoring is growing in clinical applicability generally, and AMID is an excellent target for this valuable approach to patient care. The ForeseeHome®preferential hyperacuity perimeter is a telemedicine home-based monitoring system and has been proven to improve visual outcomes in patients suffering from AMID. The development of ForeseeHome is the result of a global cooperative effort to change the lives of people with AMID by using a simple at-home test. As is true for other successes in biomedicine, this program was founded on excellent basic science, strong engineering, an experienced, dedicated team and well-designed clin-ical trials showing unquestionable efficacy.

Chapter Contents:

  • 4.1 Introduction
  • 4.2 Background
  • 4.2.1 The eye 58
  • 4.3 Diagnostic testing
  • 4.4 Age-related macular degeneration
  • 4.5 Treatment for exudative age-related macular degeneration
  • 4.6 The importance of early detection of exudative agerelated macular degeneration to improve visual outcomes
  • 4.7 The unmet needs for better early detection of exudative AMD
  • 4.8 Preferential hyperacuity perimetry (PHP)
  • 4.9 ForeseeHome
  • 4.10 Clinical trial results
  • 4.11 Impact, reimbursement and cost effectiveness of ForeseeHome monitoring
  • 4.12 Additional applications for ForeseeHome
  • 4.13 Conclusions and future of home monitoring in ophthalmology
  • References

Inspec keywords: patient diagnosis; patient care; telemedicine; patient monitoring; vision defects

Other keywords: age-related macular degeneration; vision loss; patient care; ForeseeHome® preferential hyperacuity perimeter; remote patient monitoring; telemedicine home-based monitoring system

Subjects: Patient care and treatment; Optical and laser radiation (medical uses); Patient care and treatment; Optical and laser radiation (biomedical imaging/measurement); Biomedical communication; Patient diagnostic methods and instrumentation

Preview this chapter:
Zoom in

Preferential hyperacuity perimetry: home monitoring to decrease vision loss due to age-related macular degeneration, Page 1 of 2

| /docserver/preview/fulltext/books/he/pbhe017e/PBHE017E_ch4-1.gif /docserver/preview/fulltext/books/he/pbhe017e/PBHE017E_ch4-2.gif

Related content

This is a required field
Please enter a valid email address